Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Cassava Sciences Inc (FLNA) vs Simon Property Group Inc (SPG) Price & Performance

Cassava Sciences IncTrade
Simon Property Group IncTrade

Price performance (Past 24H)

Key statistics

Cassava Sciences Inc vs Simon Property Group Inc — how do they compare? Cassava Sciences Inc trades at $0.84 (market cap $39.40M), while Simon Property Group Inc trades at $199.68 (market cap $64.59B). The key difference: Simon Property Group Inc is far larger — about 1639.3× Cassava Sciences Inc's market cap, and Simon Property Group Inc pays a 4.46% dividend while Cassava Sciences Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Cassava Sciences Inc for 37 Days and Simon Property Group Inc for 99 Days on average.

FLNASPG
Market Cap
$39.40M$64.59B
Volume
759,0181,093,907
Sector
HealthReal Estate
52-Week High
$4.64$236.70
52-Week Low
$0.68$173.35
Typical Hold Time
37 Days99 Days
Enterprise Value
-$43.28M$93.03B
Dividend Yield
—4.46%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Cassava Sciences Inc

FLNA trades at $0.84, up 2.72% today, with a bearish technical signal despite recent earnings beats. The company shows negative profitability metrics with ROE at -55.79% and ROA at -35.34%, though valuation ratios like EV/EBITDA of 1.03 and P/B of 0.62 suggest potential undervaluation. Recent FDA clearance for epilepsy drug trials provides a positive catalyst, but negative cash flow trends and zero revenue remain concerns.

The outlook hinges on clinical trial success and revenue generation. Analyst consensus is bullish with 67% buy ratings, but high execution risk and cash burn require careful monitoring. Near-term catalysts include Phase 2a trial initiation in 2027, while financial sustainability remains the primary challenge for investors.

Simon Property Group Inc

Simon Property Group (SPG) trades at $197.59, down 2.06% amid bearish technical signals, though fundamentals remain strong with robust profitability margins (net income margin 66.57%) and consistent revenue growth. Recent Q2 2026 earnings missed expectations, but Q4 2025 and Q1 2026 beat estimates. The company maintains solid cash flow from operations ($4.14B in 2025) and a raised dividend, while facing headwinds from rising bond yields and debt maturities.

Outlook: SPG offers value with a P/E of 14.09 below sector averages and a 42% analyst buy rating, targeting 13% upside to consensus. Risks include interest rate sensitivity, high leverage ($24.21B debt), and retail sector volatility. The stock's current pullback may present a buying opportunity for income investors, supported by strong leasing demand and strategic initiatives like the Simon Media Network launch.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

FLNA
73% Buy27% Sell
Avg holding period · 37 Days
SPG
100% Buy0% Sell
Avg holding period · 99 Days

Top news

Latest headlines on both assets

About Cassava Sciences Inc

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease

Read more on FLNA →

About Simon Property Group Inc

Simon Property Group is the second- largest real estate investment trust in the United States. Its portfolio includes an interest in 207 properties: 119 traditional malls, 69 premium outlets, 14 Mills centers (a combination of a traditional mall, outlet center, and big-box retailers), six lifestyle centers, and five other retail properties. Simon's portfolio averaged $693 in sales per square foot over the 12 months prior to the pandemic. The company also owns a 21% interest in Klepierre, a European retail company with investments in shopping centers in 16 countries, and joint venture interests in 33 premium outlets across 11 countries.

Read more on SPG →